The American Journal of Medicine
Volume 120, Issue 4, Supplement 1 , Pages S21-S25, April 2007

Potential Genetic Causes of Heterogeneity of Treatment Effects

  • David B. Goldstein, PhD

      Affiliations

    • Center for Population Genomics and Pharmacogenetics, Duke Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, USA
    • Corresponding Author InformationRequests for reprints should be addressed to David B. Goldstein, PhD, Center for Population Genomics and Pharmacogenetics, Duke Institute for Genome Sciences and Policy, Duke University, 103 Research Drive, Room 4006 GSRB II, Durham, North Carolina 27710.
    • ,
  • Anna C. Need, PhD

      Affiliations

    • Center for Population Genomics and Pharmacogenetics, Duke Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, USA
    • ,
  • Rinki Singh, MD

      Affiliations

    • Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London, London, United Kingdom
    • ,
  • Sanjay M. Sisodiya, MD, PhD

      Affiliations

    • Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London, London, United Kingdom

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0002-9343(07)00137-4

doi:10.1016/j.amjmed.2007.02.004

The American Journal of Medicine
Volume 120, Issue 4, Supplement 1 , Pages S21-S25, April 2007

Article Tools